🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

According to the social media company, the platform has removed problematic material and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of weight loss, positive testimonials and step-by-step guides for preparing or administering at residence.

Within moments of joining one group, a seller posted contact information, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Details and Pricing

Within these communities, messages display dark colored parcels with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to possibly serious health risks”.